University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients

Simple item page
dc.contributor.authorPrice, David
dc.contributor.authorHenley, William
dc.contributor.authorCarter, Victoria
dc.contributor.authorSkinner, Derek
dc.contributor.authorVella, Rebecca
dc.contributor.authorPapi, Alberto
dc.contributor.authorFabbri, Leonardo M
dc.contributor.authorKerstjens, Huib AM
dc.contributor.authorRoche, Nicolas
dc.contributor.authorSingh, Dave
dc.contributor.authorVogelmeier, Claus F
dc.contributor.authorŞen, Elif
dc.contributor.authorDelfini Cançado, José Eduardo
dc.contributor.authorKots, Maxim
dc.contributor.authorNudo, Elena
dc.contributor.authorBarile, Sara
dc.contributor.authorGeorges, George
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2023-03-28T23:08:41Z
dc.date.available2023-03-28T23:08:41Z
dc.date.embargoedUntil2023-03-29
dc.date.issued2022-12-22
dc.descriptionGrant Support: This study was funded by Chiesi Farmaceutici S.p.A. David Price has grants and unrestricted funding for investigator-initiated studies (conducted through Observational and Pragmatic Research Institute Pte Ltd) from AstraZeneca, Boehringer Ingelheim, Chiesi, Mylan, Novartis, Regeneron Pharmaceuticals, Respiratory Effectiveness Group, Sanofi Genzyme, Theravance and UK National Health Service; is a peer reviewer for grant committees of the UK Efficacy and Mechanism Evaluation programme, and Health Technology Assessment; and was an expert witness for GlaxoSmithKline.en
dc.format.extent319545
dc.identifier225178453
dc.identifiera98063f0-b09d-4269-9c2e-ee3699cd5758
dc.identifier.citationPrice, D, Henley, W, Carter, V, Skinner, D, Vella, R, Papi, A, Fabbri, L M, Kerstjens, H AM, Roche, N, Singh, D, Vogelmeier, C F, Şen, E, Delfini Cançado, J E, Kots, M, Nudo, E, Barile, S & Georges, G 2022, 'Commencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patients', Annual Scientific Meetings of The Australia and New Zealand Society of Respiratory Science and The Thoracic Society of Australia and New Zealand, Christchurch, New Zealand, 25/03/23 - 28/03/23.en
dc.identifier.citationconferenceen
dc.identifier.urihttps://hdl.handle.net/2164/20357
dc.language.isoeng
dc.subjectparticle sizeen
dc.subjectICSen
dc.subjectpneumoniaen
dc.subjectCOPDen
dc.subjectextrafineen
dc.subjectR Medicineen
dc.subject.lccRen
dc.titleCommencement of fixed dose ICS of varying particle size as a predictor of pneumonia in COPD patientsen
dc.typeConference itemen

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Price_Abstract_Commencement_fixed_dose.docx
Size:
312.06 KB
Format:
Unknown data format
Download

Collections

All research

The Sir Duncan Rice Library

University of Aberdeen

Bedford Road

Aberdeen

AB24 3AA


Tel: +44 (0)1224 273330

Email: library@abdn.ac.uk

Share and keep up to date


FacebookTwitterWordpress